Drug recall · November 24, 2021
Cartia XT recall
Why: Labelling: Incorrect Exp. Date
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90
- Lots / codes
Lot # 100023805, Exp. Date 05/2023
- Quantity
- 32316 bottles
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- Distributed Nationwide in the USA
- Initiated
- October 27, 2021 · Voluntary: Firm initiated
- Classified
- November 15, 2021
- Reported
- November 24, 2021
- Ended
- December 21, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cartia
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.